sclerosing agents

sclerosing agents

used to create scar tissue and obliterate a lumen or fix a moving part. Called also internal blister, e.g. ethanolamine oleate, sodium iodide.
References in periodicals archive ?
7] Recently, percutaneous aspiration of renal cysts along with injection of sclerosing agents (such as alcohol) have been explored as a potential treatment option.
A number of sclerosing agents are available, including a hypertonic solution of sodium chloride (23.
The procedure involves use of coils and sclerosing agents to block blood flow to the dilated vessels in the varicocele.
Alternatively, percutaneous embolization methods used are sclerosing agents (sobutyl-2-cyanoacrylate), absorbable gelatin sponges, or detachable balloons in the artery feeding the false aneurysm.
Lymphangiomatous macroglossia (LM) has been treated with aspiration of the lymphatic fluid and either instillation or direct injection of sclerosing agents such as Ethibloc, pure ethanol, sodium tetradecyl sulfate, hypertonic saline, OK-432 (a killed strain of group A Streptococcus), bleomycin, or boiling water.
Several sclerosing agents have been used for sclerotherapy, including ethanol, povidoneiodine, acetic acid, minocycline hydrochloride, hypertonic saline, and tetracycline.
Less commonly, other sclerosing agents or isotopes have also been used.
12) Evidence is mounting for the use of nitric oxide donor therapy (GTN patches), extracorporeal shockwave therapy (ESWT) and sclerosing agents.
This study describes our experience in treating patients with recurrent hepatic hydrothorax by chemical pleurodesis using 3 sclerosing agents as an important palliative option.
Interventional radiologists have been using various occlusion coils and sclerosing agents (typically ethanol) for decades to successfully and safely obliterate arteriovenous malformations, varicoceles, and other unwanted veins, so their application to varicose veins seemed a logical extension to physicians at the Mayo Clinic, Dr.
In the field of phlebology Kreussler Pharma has developed "Aethoxysklerol(TM)", a range of sclerosing agents marketed in more than 50 countries for ambulatory, non-surgical injection treatment of varicose veins of different diameters, haemorrhoids and oesophageal varices, without additional local anaesthetics.
During endovascular embolisation, factors such as induced hypotension, flow arrest, vasospasm due to sclerosing agents, haemodilution caused by the dextrose flush prior to glue embolisation may also contribute to acute reduction of BIS in addition to catheter-related vessel injury and bleeding.